![Australian Prescriber Podcast podcast](/assets/images/square.png)
0:00
17:37
Jo Cheah chats with clinical pharmacologist Richard Day about off-label prescribing. Ric explains why off-label prescribing occurs, the barriers to getting new indications added to a drug’s approved label, and the potential risks of off-label prescribing without sufficient evidence. Read the full article by Richard Day in Australian Prescriber.
Mais episódios de "Australian Prescriber Podcast"
Não percas um episódio de “Australian Prescriber Podcast” e subscrevê-lo na aplicação GetPodcast.